Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LMT
8. USO
9. META
10. TLT

Go back to Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights

Xeris Pharmaceuticals Inc. (XERS) Misses Q3 EPS by 2c

November 10, 2021 7:22 AM EST

Xeris Pharmaceuticals Inc. (NASDAQ: XERS) reported Q3 EPS of ($0.39), $0.02 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $11 million versus the consensus estimate of $11.03 million.

For earnings history and earnings-related data on Xeris Pharmaceuticals Inc. (XERS) click here.

... More